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Introduction
Scientific value and integrity of biomedical research is 
closely related to responsible and humanitarian treatment 
of animals.  Animal research is enormously useful because 
understanding the complex interactions of molecular, bio-
chemical and physiological mechanisms ultimately depends 
on the study of the intact organisms in vivo.  To be carried 
out, such researches involve genetic and environmental fac-
tors that are difficult, if not impossible to control by stud-
ies on humans – though such experiences are valuable only 
if these controls are maintained with care.  In addition, an 
experimental design that produces major pain or suffering 
declines subjects, if not eliminates the scientific value of the 
experiment.  Finally, irresponsible or inhuman treatment of 
animals diminishes the reputation of scientific institutions, 
jeopardizing funding and threatens the public image of 
science.
Animal experiments had a remarkable contribution to 
the discovery of treatments for various diseases.  It is enough 
to remember Paulescu’s researches, and especially the suc-
cess of the Canadian student Charles Herbert and his tutors, 
Dr. Banting and Prof. MacLeod (last two Nobel laureates) 
who, experimenting on dogs, discovered insulin hormone 
drug that saved in the last hundred yeas millions of lives. 
Animal experiments are necessary, as the experiments held 
on sick or healthy volunteers are necessary, even though 
there is no immediate benefit. 
In the Helsinki Declaration, adopted in 1964 by the 
World Medical Association (WMA), which is a guide with 
recommendations for physicians involved in biomedical re-
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search on human subjects is mentioned that research on hu-
man subjects must be based on accepted scientific principles 
and evidence obtained through laboratory experiments on 
animals [1].
Animal protection legislation exists over 80 years (in the 
UK from 1911) and is functional in many European coun-
tries.  Subsequently, many countries have adopted codes of 
practice to protect animals used in research.  Each Ethics 
Committee monitors compliance with codes of practice and 
codes of ethics regarding animal experiments [2].
Since the twentieth century, the use of animals for exper-
imental purposes extends beyond the fields of pharmacol-
ogy and physiology, being used in fields such as psychology, 
cosmetics testing, testing different medicinal products and 
other consumer products.
It is impossible to do research using laboratory animals 
and not to create a minimum of discomfort to them.  The 
need to reduce animal suffering probably arose with the 
need to use them, but today this is of major importance. 
As we move into an accelerated pace of scientific investiga-
tions, new problems for the care and use of laboratory ani-
mals continue to occur.  The main question that gives rise 
to these debates is that whether it is correct or not correct, 
morally speaking, to conduct animal research.  Scientists 
who use animals for such purposes know the problem and 
understand that experiments should be done as humanely 
as possible and that we should not use animals as long as the 
testing methods produce similar results.
There are two positions in animal experiments: in favor 
of animal experiments, only under the following conditions: 
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if their suffering is very small and if the human benefits 
derived from experiments could not be detected by other 
methods; against animal testing: if the experiments cause 
suffering, if human benefits are not proven and if you can 
make these experiments by other methods [3].
The use of animals in research is essential for the devel-
opment and production of new drugs. Animal experiments 
are provided by the laws of all countries, because it is not al-
lowed that any potential drug substance to be tested directly 
on humans.  In order to reduce the number of animals, the 
“rule of three R” (replacement, reduction, refinement) is ap-
plied [4].  Russell and Burch (1959) proposed three specific 
strategies to minimize animal pain and stress research:
 Replacement: the researcher has to ensure that the ob-
jectives of the study cannot be achieved by alternative
methods.  Where possible, conscious animals should
be replaced by unconscious animals or by insensitive
material and higher-ranking animals should be replaced
by lower-ranking ones.
 Reduction: if the number of animals involved in the
experiment is higher, there is more suffering and more
costs.  Experiments that have a good design can be
performed with a smaller number of animals without
reducing scientific expectations.  If the significance or
accuracy of a study is not compromised, fewer animals
should be used.
 Refinement: change of accommodation and experimen-
tal procedures so as to minimize the pain and stress and
to promote the welfare of animals used in research, from
birth until their death.
Strategies for reducing, replacing and refining not only 
have ethical bases, but also practical advantages.  If the ex-
periments can be made, for example, using the mice instead 
of the dogs, with less or no animals, the cost of these trials 
will be lower.
Successful implementation of the 3Rs principle strictly 
depends on the education and training of personnel involved 
in animal testing [5].
Continuous training is necessary for minimizing ani-
mal pain and the distress caused to animals, accumulation 
of theoretical and practical knowledge for the safety of the 
personnel, all leading to satisfactory scientific expectations. 
Increasing scientific quality is achieved only when the unit 
activities are preceded, the staff is trained, equipped with re-
sponsibility and strict records exist [6].  
Another critical step in performing the experiment is 
given by the extraction, processing and dissemination.  Re-
sults must be reliable, reproducible and provide repetition. 
Dissemination is mandatory regardless of the conclusions. 
Regardless of the form of dissemination, disseminating ma-
terial must contain the following data about animals (spe-
cies, line, strain, source, type, number, age, sex, weight and 
clinical status), the design of the experimental protocol (pro-
cedures used, time periods, equipment used) and analytical 
methods (including statistical methods).  Even though a 
study had an appropriate design, it is useless if the results 
were not processed fairly and were not disseminated [7].
Organization for Economic Cooperation and Develop-
ment (OECD) – a unique forum where the governments of 
33 democracies work together to respond to the economic, 
social, those related to globalization and exploitation of glo-
balized opportunities has developed and approved in 1981, 
the principles of good laboratory Practice (GLP) [OECD. 
Principles of Good Laboratory Practice (GLP)] use organi-
zational and scientific methods, and experiences of various 
national and international sources, the specific objectives 
are mentioned related to the growth and maintenance of 
laboratory animals.  The increased interest in recent years to 
medical experiments on animals is caused by a new scien-
tific understanding; sustainable, humanistic and integrative 
view characterizing the millennium.  The use of animals for 
research is under control in some EU countries under the 
provisions of the “European Convention for the protection 
of vertebrate animals used for experimental and other scien-
tific purposes” [8].
In the Republic of Moldova, Law on the protection of 
animals nr.265 used for experimental and other scientific 
purposes was adopted by Parliament in July 2006 [9].
At the same time implementation of the recommenda-
tions of ISO/IEC 17025, 15190 in biomedical research cen-
ters of the country has as a goal the proper management 
of clinical and laboratory facilities needed to ensure their 
objects of study.  In the researches conducted on animals, it 
would be ideal that the animal preserve stability in physi-
ological status such as the response to variability of inter-
est not to be interfered with unwanted influence.  If animal 
welfare is compromised, consequences may include: high 
variability in results, the need to increase the number of 
animals, incomplete data, data that cannot be analyzed 
with low credibility, results that cannot be applied in other 
situations and the impossibility of publishing.  Maintaining 
the animal welfare, identifying, controlling and eliminat-
ing factors that cause physiological and behavioral distur-
bances show good scientific practice.  Under this context 
the Scientific Center of Drug Research team has set as a goal 
and is working on the implementation of standards GLP 
(Good Laboratory Practice) in preclinical study in practical 
science activities of Nicolae Testemitsanu State University 
of Medicine and Pharmacy.  An important role in this di-
rection is the work of the Ethics Committee of the univer-
sity research.
In EU countries there is a tendency of standardizing the 
functionality of Ethics Committees, the European Federa-
tion of Associations of Laboratory Animal Science (FELA-
SA) has published “Principles of ethical review practice 
for animal experiments in Europe” [10].  Regardless of the 
name, a control organization to assess animal research is 
required to ensure implementation of the concept of ethics 
in animal experiments and should be structured in several 
categories of people (doctors, researchers, neutral staff, staff 
from the animal protection associations, lawyers, philoso-
phers, priests, etc.) to be neutral to the institutions initiating 
animal studies.
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Conclusions
1. Human attitude towards animals is a relevant marker
of ethical posture and level of civilization. 
2. Experimental Ethics is prerequisite for ensuring good
scientific practice.  The existence of a regulatory body to pro-
vide advice and evaluation of experimental design becomes 
mandatory enforcement of the concept of ethics in animal 
experiments. 
3. In order not to eliminate the scientific value of ani-
mal experiments in our country, it is necessary to implement 
Good Laboratory Practice standards.
References
1. Regulile pentru buna practică în studiul clinic (ICH Guide For Good 
Clinical Practice) [Good Laboratory Practice in clinical research]. Bu-
letinul INF (ediţie specială) [Journal of National Institute of Pharmacy]. 
2002;195.
2. Zimmerman M. Ethical guidelines for investigations of experimental 
pain in conscious animals. Pain. 1983;16:109-110.
3. Cristea A. Bioetica cercetării ştiinţifice pe animale de experienţă [Bioeth-
ics of scientific research on experiments animal]. Farmacia [Pharmacy]. 
1997;XLV(3):15-17. 
4. Russel WMS, Burch RL. The principles of humane experimental tech-
nique. Wheathampstead: Universities Federation for Animal Welfare, 
1959. [reprinted 1992].
5. Balls M, Goldberg A, Fentem J, et al. The Three Rs: The way forward. 
ATLA. 1995;23(6):838-866.
6. Festing M, Overend P, Das RG, et al. Reducing the use of animals in 
research through better experimental design. Laboratory Animal LTD. 
London, 2008.
7. Pence GE. Classic cases in Medical Ethics - Accounts of the cases that 
have shaped Medical Ethics, with Philosophical, Legal and Historical 
Backgrounds. McGraw-Hill, Inc. USA, 1990.
8. Handbook for Good Laboratory Practice (GLP). Quality practices for 
regulated non-clinical research and development. World Health Orga-
nization. 2009;328.
9. Legea privind protecţia animalelor folosite în scopuri experimentale 
sau în alte scopuri ştiinţifice [Law regarding the protection of animals 
used for experimental purpose or other scientific purposes]. Monitorul 
Oficial. Nr. 168-169.
10. Decun M, Bodnariu A. Experimentarea pe animale în România, anali-
zat din perspectiva europeană [Experiments on animals in Romania, 
analysed from european perspectives]. Revista Română de Bioetică 
[Romanian Journal of Bioethics]. 2009;7(3).
57
Curierul medical, August 2015, Vol. 58, No 4
